Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Bloodstream infection" patented technology

Blood infection is a condition characterized by the presence of bacteria in the blood. It may be caused by other pathogens as well. The forthcoming passages provide in-depth information about this medical condition. When bacteria invade the bloodstream, the condition is termed as 'blood infection'. It is also known as bacteremia.

Bloodstream infection related septic shock multi-modal fusion prediction method and system

PendingCN122455352AFeature vectorEngineering
The application provides a blood stream infection related septic shock multi-modal fusion prediction method and system, belonging to the field of intelligent medical treatment, and solving the problems of long time consumption, insufficient sensitivity and insufficient multi-modal information analysis capability in blood stream infection related septic shock. The method comprises: acquiring multi-modal clinical data of a target patient suspected of blood stream infection within a preset observation time window to obtain a multi-modal multi-scale feature sequence formed by combining each modality spatiotemporal feature vector sequence; inputting the multi-modal multi-scale feature sequence into a time sequence encoding network based on a multi-head attention mechanism to obtain an aligned multi-modal time sequence representation sequence; setting a learnable modality weight parameter for each modality, and updating the learnable modality weight parameter, the encoder and the time sequence encoding network through a task loss function according to the label of whether blood stream infection related septic shock occurs or not in the training process to obtain a multi-modal fusion model for prediction.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

A low-infection-risk detachable fixed-wing and recess-free fluid-stopping hemodialysis catheter system

PendingCN122272936AExtended service lifeimprove securityBlood flowMechanical lesion
This invention discloses a low-infection-risk detachable fixation wing and grooveless stop clamp hemodialysis catheter system, belonging to the field of medical device technology. This invention addresses two core pain points of existing long-term hemodialysis catheters: first, it redesigns the traditional one-piece fixation wing as a detachable structure, allowing for quick assembly and disassembly by external force without damaging the catheter, facilitating skin cleaning and reducing the risk of local infection and mechanical damage; second, it optimizes the separate stop clamp into a grooveless structure integrated with the connector, employing a full, smooth inner lumen to completely eliminate dead zones for bacterial residue, reducing catheter-related bloodstream infections at the source. This invention has a simple structure, strong clinical adaptability, and can be widely applied in the field of long-term hemodialysis treatment, demonstrating significant clinical application value.
Owner:曾梓群

Biomarkers for the treatment of bloodstream infections and gastrointestinal diseases

PCT designated stageWO2026128884A2Peptide/protein ingredientsMaterial analysisDiseaseBacterial composition
Provided herein are biomarkers that are useful in various aspects of treating and preventing complications and side effects associated with a disease or disorder, such as those associated with immune suppression, disruption of the gastrointestinal microbiome, infections (e.g., bloodstream infections), and / or GvHD, for example, in HSCT subjects. In some aspects, the biomarkers provided herein can be used in identifying a subject who is responding to a bacterial composition and / or subjects that are suitable for a treatment with a bacterial composition.
Owner:SERES THERAPEUTICS INC

Biomarkers for the treatment of bloodstream infections and gastrointestinal diseases

PCT designated stageWO2026128884A3DiseaseBacterial composition
Provided herein are biomarkers that are useful in various aspects of treating and preventing complications and side effects associated with a disease or disorder, such as those associated with immune suppression, disruption of the gastrointestinal microbiome, infections (e.g., bloodstream infections), and / or GvHD, for example, in HSCT subjects. In some aspects, the biomarkers provided herein can be used in identifying a subject who is responding to a bacterial composition and / or subjects that are suitable for a treatment with a bacterial composition.
Owner:SERES THERAPEUTICS INC